Related Experiment Video
Updated: Aug 23, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
A subacute presentation of Mycoplasma hominis prosthetic valve endocarditis
Myong Gyu Joshua Kim1,2, Susannah Payne2, Jeffrey Post3,2
1Faculty of Medicine, Prince of Wales Clinical School, University of New South Wales, Randwick, New South Wales, Australia myonggyu.kim@health.nsw.gov.au.
Abstract:
Mycoplasma hominis is a rare but important cause of prosthetic valve endocarditis. It is usually associated with acute progression of symptoms and can be difficult to diagnose as it does not grow in standard culture media. We report a case of an immunocompetent man in his 70s who presented with 14-month subacute decline with shortness of breath and evidence of a splenic infarct. Following a redo aortic valve replacement and diagnosis of M. hominis through 16S ribosomal ribonucleic acid PCR, he improved clinically with oral doxycycline therapy. He remained well at follow-up 2 years post-cessation of antibiotics. We present a literature review highlighting the role of PCR testing in the microbiological identification of M. hominis.
Insights
Mycoplasma hominis can cause prosthetic valve endocarditis and is hard to detect with standard cultures. PCR testing identified this rare pathogen, leading to successful treatment with doxycycline.
Area of Science:
- Infectious Diseases
- Cardiology
- Microbiology
Background:
- Prosthetic valve endocarditis (PVE) is a serious complication, often caused by common bacteria.
- Mycoplasma hominis is a rare but significant cause of PVE, presenting diagnostic challenges due to its fastidious growth requirements.
- Standard microbiological culture methods often fail to detect M. hominis in clinical samples.
Observation:
- A case of a subacute decline over 14 months in an immunocompetent elderly male with shortness of breath and splenic infarct.
- The patient had undergone a previous aortic valve replacement, suggesting prosthetic valve endocarditis.
- Initial diagnostic workup did not identify the causative agent using conventional methods.
Findings:
- Diagnosis of Mycoplasma hominis was achieved through 16S ribosomal RNA (rRNA) polymerase chain reaction (PCR) testing.
- The patient showed significant clinical improvement following redo aortic valve replacement and treatment with oral doxycycline.
- Long-term follow-up confirmed sustained recovery 2 years after antibiotic cessation.
Implications:
- 16S rRNA PCR is a valuable tool for the microbiological identification of difficult-to-culture pathogens like Mycoplasma hominis in PVE.
- Early and accurate diagnosis of M. hominis PVE can lead to effective targeted therapy and improved patient outcomes.
- This case highlights the importance of considering atypical organisms in prosthetic valve endocarditis, especially when standard cultures are negative.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Mitral Stenosis I: Introduction
Endocarditis IV: Nursing Management
Mitral Stenosis III: Medical Management

